Anticoagulation in Post MI LV Thrombus Trial in Nepal — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Anticoagulation in Post MI LV Thrombus Trial in Nepal — Stella

Recruiting

Back to Left Ventricular Thrombus trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Nepal

Nepal Health Research Council, Kathmandu, Bagmati

Key details

Phase

Post-approval study

Sponsor

Shahid Gangalal National Heart Centre

Enrollment target

~196 participants

Started

June 2023

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov